Mucinous Cancers have Fewer Genomic Alterations than More Common Classes of Breast Cancer

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.76, Iss.3, 2002-12, pp. : 255-260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mucinous Gastric Cancer Presents with More Advanced Tumor Stage and Weaker -Catenin Expression than Nonmucinous Cancer

By Choi Min-Gew

Annals of Surgical Oncology, Vol. 17, Iss. 11, 2010-11 ,pp. : 3053-3058

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study evaluating lapatinib in combination with nab -paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherapeutic regimen

By Yardley Denise

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 457-464

Springer Publishing Company

Access to resources Recommend Favorite

FHIT alterations in breast cancer

By Ingvarsson S.

Seminars in Cancer Biology, Vol. 11, Iss. 5, 2001-10 ,pp. : 361-366

Academic Press

Access to resources Recommend Favorite

From chromosomal alterations to target genes for therapy: integrating cytogenetic and functional genomic views of the breast cancer genome

By Monni O. Hyman E. Mousses S. Barlund M. Kallioniemi A. Kallioniemi O-P.

Seminars in Cancer Biology, Vol. 11, Iss. 5, 2001-10 ,pp. : 395-401

Academic Press

Access to resources Recommend Favorite

Genomic alterations in DNA repair and chromatin remodeling genes in estrogen receptor‐positive metastatic breast cancer patients with exceptional responses to capecitabine

Cancer Medicine, Vol. 4, Iss. 8, 2015-08 ,pp. : 1289-1293

John Wiley & Sons Inc

Access to resources Recommend Favorite